Reproductive health in women with systemic lupus erythematosus compared to population controls

Scandinavian Journal of Rheumatology

Volumn 38, Issue 5, 2009, Pages 375-380

  Ekblom Kullberg, S ^a   Kautiainen, H ^b   Alha, P ^c   Helve, T ^a   Leirisalo Repo, M ^a   Julkunen, H ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b RHEUMATISM FOUNDATION HOSPITAL   (Finland)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; ORAL CONTRACEPTIVE AGENT; PROGESTERONE;

ADULT; AGED; ANAMNESIS; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; FAMILY SIZE; FEMALE; FEMALE INFERTILITY; FINLAND; HORMONE SUBSTITUTION; HUMAN; INDUCED ABORTION; INTRAUTERINE CONTRACEPTIVE DEVICE; INTRAUTERINE GROWTH RETARDATION; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MENARCHE; MENSTRUATION; ORAL CONTRACEPTION; PREECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PREMATURITY; PRIORITY JOURNAL; REPRODUCTIVE HEALTH; SOCIAL STATUS; SPONTANEOUS ABORTION; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; CHI-SQUARE DISTRIBUTION; FEMALE; GRAVIDITY; HEALTH STATUS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MENOPAUSE; MENSTRUATION; PREGNANCY; QUESTIONNAIRES; REPRODUCTIVE BEHAVIOR; STATISTICS, NONPARAMETRIC;

EID: 70350053430     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.1080/03009740902763099     Document Type: Article

References (37)

1. Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P, et al. Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on Systemic Lupus Erythematosus. Medicine 1993;/72:/113-124. (Pubitemid 23097765)
2. Gayed M, Gordon C. Pregnancy and rheumatic diseases. Rheumatology (Oxford) 2007;/46:/1634-1640.
3. Askanase AD, Buyon JP. Reproductive health in SLE. Best Pract Res Clin Rheumatol 2002;/16:/265-280.
4. Khamashta MA, Hughes GR. Pregnancy in systemic lupus erythematosus. Curr Opin Rheumatol 1996;/8:/424-429.
5. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum ;25 1982;/ 1982:/1271-1277.
6. Helve T. Prevalence and mortality rates of systemic lupus erythematosus and causes of death in SLE patients in Finland. Scand J Rheumatol 1985;/14:/43-46.
7. Aromaa A, Koskinen S, editors. Health and functional capacity in Finland. Baseline results of the Health 2000 health examination survey. Helsinki: National Public Health Institute, 2004.
8. Fraga A, Mintz G, Orozco H. Fertility rates, fetal wastage and maternal morbidity in SLE. J Rheumatol 1974;/1:/293-298.
9. Gonzales-Crespo MR, Gomez-Reino JJ, Merino R, Ciruelo E, Gomez-Reino FJ, Muley R, et al. Menstrual disorders in girls with systemic lupus erythematosus treated with cyclophosphamide. Br J Rheumatol 1995;/34:/737-41.
10. McDermott EM, Powell RJ. Incidence of ovarian failure in systemic lupus erythematosus after treatment with pulse cyclophosphamide. Ann Rheum Dis 1996;/55:/224-229.
11. Contreras G, Tozman E, Nahar N, Metz D. Maintenance therapies for proliferative lupus nephritis: mycophenolate mofetil, azathioprine and intravenous cyclophosphamide. Lupus 2005;/14(Suppl 1):/33-38.
12. Tinelli A, Tinelli R, Malvasi A, Cavallotti C, Tinelli FG. The intrauterine device in modern contraception: still an actuality? Eur J Contracept Reprod Health Care 2006;/11:/197-201.
13. Jungers P, Dougados M, Pelissier C. Influence of oral contraceptive therapy on the activity of systemic lupus erythematosus. Arthritis Rheum 1982;/25:/618-623. (Pubitemid 12078974)
14. Julkunen H. Oral contraceptives in systemic lupus erythematosus: side-effects and influence on the activity of SLE. Scand J Rheumatol 1991;/20:/427-433.
15. Asherson RA, Harris EN, Hughes GRV, Farquharson RG. Complications of oral contraceptives and antiphospholipid antibodies. Arthritis Rheum 1988;/31:/575-576.
16. Julkunen H, Kaaja R, Friman C. Contraceptive practice in women with systemic lupus erythematosus. Br J Rheumatol 1993;/32:/227-230.
17. Backman T. Benefit-risk assessment of the levonorgestrel intrauterine system in contraception. Drug Saf 2004;/27:/1185-1204. (Pubitemid 40066081)
18. Bruce IN. Atherogenesis and autoimmune disease: the model of lupus. Lupus 2005;/14:/687-690.
19. Mok CC. Accelerated atherosclerosis, arterial thromboembolism, and preventive strategies in systemic lupus erythematosus. Scand J Rheumatol 2006;/35:/85-95.
20. Petri M. Exogenous estrogen in systemic lupus erythematosus: oral contraceptives and hormone replacement therapy. Lupus 2001;/10:/222-226.
21. Lakasing L, Khamashta M. Contraceptive practices in women with systemic lupus erythematosus and/or antiphospholipid syndrome: what advice should we be giving? J Fam Plann Reprod Health Care 2001;/27:/7-12.
22. Sánchez-Guerrero J, González-Pérez M, Durand-Carbajal M, Lara-Reyes P, Jiménez-Santana L, Romero-Diaz J, et al. Menopause hormonal therapy in women with systemic lupus erythematosus. Arthritis Rheum 2007;/56:/3070-3079.
23. Petri M, Kim MY, Kalunian KC, Grossman J, Hahn BH, Sammaritano LR, et al. Combined oral contraceptives in women with systemic lupus erythematosus. N Engl J Med 2005;/353:/2550-2558.
24. Tinzani A, Nuzzo M, Lojacono A, Cattalini M, Meini A. Review: contraception in adolescents with systemic lupus erythematosus. Lupus 2007;/16:/600-605.
25. Gompel A, Piette JC. Systemic lupus erythematosus and hormone replacement therapy. Menopause Int 2007;/ 13:/65-70.
26. Buyon JP, Petri MA, Kim MY, Kalunian KC, Grossman J, Hahn BH, et al. The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial. Ann Intern Med 2005;/142:/953-962.
27. Fernandez M, Calvo-Alén J, Bertoli AM, Bastian HM, Fessler BJ, McGwin G Jr, et al. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA L II): relationship between vascular events and the use of hormone replacement therapy in postmenopausal women. J Clin Rheumatol 2007;/ 13:/261-265.
28. Lima F, Buchanan NM, Khamashta MA, Kerslake S, Hughes GR. Obstetric outcome in systemic lupus erythematosus. Semin Arthritis Rheum 1995;/25:/184-192.
29. Cortés-Hernandéz J, Ordi-Ros J, Paredes F, Casellas M, Castillo F, Vilardell-Tarres M. Clinical predictors of fetal and maternal outcome in systemic lupus erythematosus: a prospective study of 103 pregnancies. Rheumatology (Oxford) 2002;/41:/643-650.
30. Silver RM, Branch DW. Autoimmune disease in pregnancy. Baillieres Clin Obstet Gynaecol 1992;/6:/565-600.
31. Facts about social welfare and health care in Finland 2006. Research and Development Centre for Welfare and Health (STAKES), Finland. Available online at: www.stakes.fi/NR/rdonlyres/FB044FF9-72F0-4EDA-8B02-EC2AE4AC966F/0/Facts2006. pdf (accessed January 2008).
32. Statistics and registers. National Institute for Health and Welfare, Finland. Available online at: www.stakes.fi/EN/tilastot/ statisticsbytopic/ reproduction/parturients.htm (accessed January 2008).
33. Julkunen H, Jouhikainen T, Kaaja R, Leirisalo-Repo M, Stephansson E, Palosuo T, et al. Fetal outcome in lupus pregnancy: a retrospective case-control study of 242 pregnancies in 112 patients. Lupus 1993;/2:/125-131.
34. Petri M, Allbritton J. Fetal outcome of lupus pregnancy: a retrospective case-control study of the Hopkins lupus cohort. J Rheumatol 1993;/20:/650-656.
35. Mok CC, Wong RW. Pregnancy in systemic lupus erythematosus. Postgrad Med J 2001;/77:/157-165.
36. Julkunen H, Eronen M. Long-term outcome of mothers of children with isolated heart block in Finland. Arthritis Rheum 2001;/44:/647-652. (Pubitemid 32234623)
37. Julkunen H, Miettinen A, Walle T, Chan EKL, Eronen M. Immune response in mothers of children with isolated congenital and acquired heart block: a population based study. J Rheumatol 2004;/31:/183-189.